Why are some markers flagged as abnormal on my Quest report?

Quest Diagnostics flags biomarkers as abnormal when they fall outside standard reference ranges, which represent values for 95% of healthy people. However, these ranges don't account for optimal levels, individual variations, or your unique health context.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Quest's flagging system

When you receive your Quest Diagnostics lab report, you might notice certain values marked with an 'H' for high or 'L' for low, accompanied by bold text or special highlighting. These flags indicate that your result falls outside the laboratory's established reference range for that particular biomarker. While these flags can be concerning at first glance, understanding what they actually mean is crucial for interpreting your health data accurately.

Quest uses a standardized system where any value outside the reference range gets automatically flagged, regardless of how slightly it deviates from the 'normal' range. This binary approach means a value of 101 in a range of 0-100 receives the same flag as a value of 200, even though the clinical significance may be vastly different.

What are reference ranges and how are they determined?

Reference ranges represent the values found in 95% of healthy individuals in a reference population. These ranges are established by testing large groups of apparently healthy people and using statistical methods to determine where most values fall. Typically, labs use the middle 95% of results, meaning that 2.5% of healthy people will have values below the range and 2.5% will have values above it.

Evaluating the Significance of Abnormal Flags

Flag TypeLevel of ConcernExamplesRecommended Action
Slightly out of rangeSlightly out of range (5-10% beyond limits)LowCholesterol 205 (range <200), Vitamin D 29 (range 30-100)Monitor, retest in 3-6 months, lifestyle modifications
Moderately elevatedModerately elevated/low (10-50% beyond limits)ModerateALT 75 (range 0-44), TSH 6.5 (range 0.4-4.5)Consult healthcare provider, investigate causes, retest sooner
Significantly abnormalSignificantly abnormal (>50% beyond limits)HighGlucose 250 (range 70-99), Creatinine 3.0 (range 0.7-1.3)Seek immediate medical attention, comprehensive evaluation needed
Critical valuesCritical valuesUrgentPotassium <2.5 or >6.5, Hemoglobin <7Immediate medical care required, may need emergency treatment

This table provides general guidance. Always consult with a healthcare provider for proper interpretation of your specific results.

This statistical approach has important implications. Even if you're perfectly healthy, there's a 5% chance that any given biomarker will fall outside the reference range purely by chance. When you test 20 or more biomarkers, as many comprehensive panels do, it's statistically likely that at least one will be flagged as abnormal even in completely healthy individuals.

Population-based vs. personalized ranges

Quest's reference ranges are based on broad population averages and don't account for individual factors that can significantly affect what's normal for you. Age, sex, ethnicity, fitness level, diet, medications, and even the time of day can all influence biomarker values. For example, testosterone levels naturally decline with age in men, but many labs use the same reference range for all adult males, potentially flagging normal age-related changes as abnormal.

The difference between 'normal' and 'optimal'

Perhaps most importantly, reference ranges define what's statistically common, not what's optimal for health and longevity. A fasting glucose of 99 mg/dL won't be flagged by Quest (their range typically goes up to 99 or 100), but research suggests that optimal fasting glucose for metabolic health is closer to 70-85 mg/dL. Similarly, a vitamin D level of 30 ng/mL might be within Quest's normal range, but many experts recommend levels of 40-60 ng/mL for optimal immune function and bone health.

Common reasons for abnormal flags

Pre-analytical factors

Many flagged results stem from factors related to sample collection rather than actual health issues. Dehydration can concentrate many biomarkers, leading to falsely elevated results. Not fasting properly can affect glucose, triglycerides, and other metabolic markers. Even the stress of having blood drawn can temporarily elevate cortisol and glucose levels. Exercise within 24-48 hours of testing can raise markers like creatine kinase (CK), AST, and even liver enzymes.

Biological variation

Your biomarkers naturally fluctuate throughout the day, month, and year. Cortisol follows a circadian rhythm, being highest in the morning and lowest at night. Female hormones vary dramatically throughout the menstrual cycle. Even markers we think of as stable, like cholesterol, can vary by 5-10% from day to day. A single abnormal flag might simply catch a biomarker at a natural peak or trough.

Lifestyle and environmental factors

  • Recent illness or infection can affect numerous markers, particularly white blood cell counts and inflammatory markers
  • Medications, including over-the-counter drugs and supplements, can influence many biomarkers
  • Dietary choices in the days before testing can impact lipid panels, glucose, and even some vitamin levels
  • Sleep deprivation can affect hormones, glucose metabolism, and inflammatory markers
  • Chronic stress elevates cortisol and can impact thyroid function, glucose control, and immune markers

Which abnormal flags should you worry about?

Not all abnormal flags carry equal weight. Understanding which ones warrant immediate attention versus continued monitoring can help you respond appropriately to your results. Here's how to evaluate the significance of flagged values.

Magnitude matters

A value slightly outside the reference range is very different from one that's dramatically elevated or suppressed. For most biomarkers, mild deviations (within 10-20% of the range limits) are less concerning than major departures. However, some markers like troponin or tumor markers are significant even with small elevations.

Pattern recognition

Multiple related biomarkers moving in the same direction often indicates a real issue rather than laboratory or statistical variation. For example, if both your TSH is elevated and your Free T4 is low, this pattern suggests hypothyroidism more strongly than either marker alone. Similarly, elevated ALT, AST, and GGT together point to liver involvement more definitively than a single elevated liver enzyme.

Clinical context is crucial

Abnormal flags must always be interpreted in the context of your symptoms, medical history, and other test results. An elevated white blood cell count in someone with no symptoms might be less concerning than the same elevation in someone with fever and fatigue. This is why it's essential to discuss flagged results with a healthcare provider who can consider your complete clinical picture.

How to respond to abnormal flags

When you see abnormal flags on your Quest report, resist the urge to panic. Instead, take a systematic approach to understanding and addressing these results. First, look at how far outside the range your value falls and whether you have any symptoms that might be related. Consider recent lifestyle factors that might have influenced the results.

For slightly abnormal values without symptoms, retesting in a few weeks or months often provides clarity about whether the abnormality is persistent or was a temporary fluctuation. When retesting, try to maintain consistent conditions: same time of day, same fasting status, and similar activity levels in the preceding days.

If you're interested in going beyond basic interpretation and understanding your results in the context of optimal health ranges and personalized insights, consider using SiPhox Health's free upload service. This AI-powered tool can analyze your Quest results alongside your health history and lifestyle factors to provide more nuanced interpretation than simple flag systems.

The limitations of traditional lab reporting

Quest's reporting system, while standardized and widely used, has several limitations that can make it challenging for patients to truly understand their health status. The reports typically show only current results without trending data, making it impossible to see if your biomarkers are improving or declining over time. They also lack integration with other health data like wearables, symptoms, or lifestyle factors that could provide important context.

Most significantly, traditional lab reports don't provide personalized recommendations for addressing abnormal values. You might see that your vitamin D is low, but the report won't tell you how much supplementation you need or what lifestyle changes could help. This gap between data and actionable insights is where many people struggle with their lab results.

Moving beyond flags to optimization

While Quest's abnormal flags serve as a useful starting point for identifying potential health issues, optimal health requires a more sophisticated approach to biomarker interpretation. This includes tracking trends over time, understanding optimal versus normal ranges, and receiving personalized recommendations based on your unique health profile and goals.

Modern health optimization platforms can transform your static lab report into a dynamic health dashboard. By uploading your Quest results to Sai, SiPhox Health's AI health optimization expert, you can receive personalized insights that go far beyond simple flag identification. Sai analyzes your biomarkers in context, identifies patterns across multiple markers, and provides evidence-based recommendations for improving your health metrics.

The future of health monitoring isn't just about identifying when something is wrong - it's about optimizing your biomarkers for longevity, performance, and wellbeing. By understanding why markers get flagged and how to interpret them in context, you can move from reactive healthcare to proactive health optimization. Whether you're dealing with a few abnormal flags or looking to optimize already 'normal' results, the key is to view your biomarkers as dynamic indicators that can be influenced and improved through targeted interventions.

References

  1. Friedberg RC, Souers R, Wagar EA, Stankovic AK, Valenstein PN. The origin of reference intervals. Archives of Pathology & Laboratory Medicine. 2007;131(3):348-357.[PubMed]
  2. Ozarda Y. Reference intervals: current status, recent developments and future considerations. Biochemia Medica. 2016;26(1):5-16.[PubMed][DOI]
  3. Fraser CG. Biological variation: from principles to practice. Washington, DC: AACC Press; 2001.[Link]
  4. Sikaris KA. Physiology and its importance for reference intervals. Clinical Biochemist Reviews. 2014;35(1):3-14.[PubMed]
  5. Jones GRD, Haeckel R, Loh TP, et al. Indirect methods for reference interval determination - review and recommendations. Clinical Chemistry and Laboratory Medicine. 2019;57(1):20-29.[PubMed][DOI]
  6. Katayev A, Balciza C, Seccombe DW. Establishing reference intervals for clinical laboratory test results: is there a better way? American Journal of Clinical Pathology. 2010;133(2):180-186.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I get a better analysis of my Quest lab results?

You can get comprehensive analysis of your Quest results using SiPhox Health's free upload service. This AI-powered tool provides personalized insights, tracks trends over time, and offers actionable recommendations based on your unique health profile, going beyond Quest's basic flagging system.

What percentage of healthy people have at least one abnormal flag?

Due to how reference ranges are calculated (covering 95% of healthy people), approximately 5% of healthy individuals will have an abnormal result for any single test. When testing 20+ biomarkers, it's statistically likely that 64% of healthy people will have at least one flagged result purely by chance.

Should I retest if I have an abnormal flag but no symptoms?

For slightly abnormal values without symptoms, retesting in 4-12 weeks is often recommended to determine if the abnormality is persistent or temporary. Maintain consistent conditions when retesting (same time of day, fasting status, and activity levels) for the most accurate comparison.

Can I talk to an AI about my specific Quest results?

Yes, you can discuss your Quest results with Sai, SiPhox Health's AI health expert. Sai can analyze your results in context, explain what abnormal flags mean for your specific situation, and provide personalized recommendations for improving your biomarkers.

What's the difference between Quest's 'normal' range and optimal levels?

Quest's normal ranges represent statistical averages from the general population, while optimal ranges are based on research showing levels associated with the best health outcomes. For example, Quest may flag fasting glucose as normal up to 99 mg/dL, but optimal levels for metabolic health are typically 70-85 mg/dL.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details